Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Regulations
Claims/Labeling
Organic/COSMOS
Safety
SPF/Sun
Regional
Safety
Safety/Stability
[updated] Could UV Affect Benzene Formation? New Findings in BPO Acne, Rosacea Products
Of some 111 OTC drug products taken from retail shelves and tested at room temperature, 34%, including brands such as Clearasil, CVS Health, La Roche-Posay and Proactiv, exceeded the FDA's conditional benzene limit. The PCPC weighed in on these findings.
Regional
Has DSM-Firmenich Put Us on a Path to a New U.S. Sunscreen Approval?
Regional
Asia-Pacific Regulatory Update: Adverse Reactions to Cosmetics, Reclassifications, TiO2, Intimate Care and More
Latest
Safety
Safety Alerts: Dynarex Baby Powder, Phthalates in Children, Proposed CBD Ban, 1,4-Dioxane Restriction in NY
Recent weeks have seen a flurry of activity related to cosmetic ingredient safety, including concerns for: asbestos in talc, phthalates in children, CBD's potential reproductive toxicity and the persistence of 1,4-dioxane in the environment.
Safety
Could the FDA's Delay to Rule on 3 Hand Soap Ingredients Spell Trouble for the Industry?
In a letter to the FDA, GSPI urged the agency to ban 3 antibacterial ingredients that have been in limbo for years. The NGO fears this delay could harm consumers as they keep using the ingredients. C&T fears it opens the industry to new scrutiny.
Sponsored
Empowering Skin’s Resilience with CefiraProtect CLR™
CLR introduces CefiraProtect CLR™, the daily companion for youthful skin. Derived from Lactobacillus kefiranofaciens, this innovative active ingredient supports skin in maintaining its oxidative balance and enhancing its self-defense mechanisms.
Safety
Legal Briefs: 18 Product Alerts in Europe, J&J Ups Talc Offer $1.1 B, Tattoo Pigment Recall, Coppertone Class Action Dropped
This legal briefing includes 18 product citations in Europe for fragrance allergens/prohibited substances; J&J's raised talc settlement offer; a tattoo pigment recalled for microbe contamination; and a dropped class action against Coppertone.
Safety
Talc Suit Updates: J&J Secures Votes for $6.5 B Deal, Loses Bankruptcy Attempt #3; Avon Files for Bankruptcy
This roundup of the latest talc/cancer-related lawsuit news includes: J&J secures 75% of votes to back $6.5 billion settlement; J&J's third bankruptcy attempt rejected; and Avon files for bankruptcy over similar talc-cancer suits. Read on for more.
Safety
4 Talc Updates — Avon's $24 M Payout; J&J's South Carolina Trial, Bankruptcy Affirmed; 2 Others in the Hotseat
Recently, Avon payed out $24 million and J&J took the stand (again) in South Carolina, both in cases alleging talc-based powders caused mesothelioma. An appeals court affirmed J&J's second bankruptcy rejection and two other companies are in the hotseat.
Safety
[interview] U.S. FDA on MoCRA: New Authority, Fragrance Allergens, Animal Testing and More
In this interview, the FDA describes its new MoCRA-mandated authorities, 5 requirements for industry (and how it will enforce them), the mandate for listing fragrance allergens, why animal testing was omitted from MoCRA and more.
Safety
J&J Talc/Cancer Update: Looming $8 B Deadline, Opposing Bankruptcy Counsel and Talc Supplier Deal
Many women in the J&J talc/ovarian cancer suit are being urged to vote for the $8 billion deal; opponents are pushing for more. J&J also sought to disqualify opposing counsel Beasley Allen, and made a deal with bankrupt talc suppliers. Here's an update.
Companies
Meeting 5 MoCRA Mandates for Adverse Event Reporting: Registrar Corp. Launches New Tool
Registrar Corp. has developed software to meet the FDA's/MoCRA's 5 stringent requirements for adverse event reporting.
Safety
MoCRA Cosmetics Act: Why Now? 8 PCPC Insights on the Legislation's Inner Workings
The Modernization of Cosmetics Regulation Act (MoCRA) is now in motion and is the first major legislation for cosmetics in the U.S. since 1938. After 85+ years, why implement it now? What concerns is it built to address and how? Here, the PCPC responds.
Regional
9 Cosmetic Ingredient Bans/Restrictions in the EU: Kojic Acid, 4-MBC, Retinol, Arbutin and More
The EU Commission officially published several amendments to EU Cosmetic Products Regulation (CPR) that will restrict or ban nine cosmetic ingredients. Read on to learn more.
